Clinical Trial: Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Schizophenia Disorder
Schizoaffective Disorder
Bipolar Disorder
Psychiatric Disorders
Study Type: INTERVENTIONAL
Official Title: Reduction of Anticholinergic Medications Project (RAMP) Among Persons With Schizophrenia or Other Psychiatric Disorders Across UPMC Behavioral Healthcare Partner Organizations Using a Stepped-wedge, R
Brief Summary:
The goal of this study is to reduce Anticholinergic Medication (ACM) in persons with psychoses or serious mental illness, when these medications are no longer needed.
Read more